Astellas Pharma is an API and finished-dose manufacturer based in Switzerland. It holds one valid CEP across a filed portfolio of 2 molecules. Its filings concentrate with MHRA (UK), DKMA (DK) and SWISSMEDIC (CH).
| Site | FDA FEI |
|---|---|
| Wallisellen, Switzerland | Not on file |
| Tokyo, Japan | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Tacrolimus | SFDA (Saudi Arabia) | 1 |
| Tamsulosin | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MHRA (UK) | 61 | None |
| DKMA (DK) | 35 | None |
| SWISSMEDIC (CH) | 31 | None |
| ANSM (FR) | 14 | None |
| SFDA (Saudi Arabia) | 13 | None |
| FAMHP (BE) | 11 | None |
Choose your molecules and target markets. Astellas Pharma comes back tiered against every other supplier able to file there.
Start for free